| Literature DB >> 30733759 |
Bikash Jaiswal1, Kumar Utkarsh1, D K Bhattacharyya1.
Abstract
In the domain of gene-gene network analysis, construction of co-expression networks and extraction of network modules have opened up enormous possibilities for exploring the role of genes in biological processes. Through such analysis, one can extract interesting behaviour of genes and would help in the discovery of genes participating in a common biological process. However, such network analysis methods in sequential processing mode often have been found time-consuming even for a moderately sized dataset. It is observed that most existing network construction techniques are capable of handling only positive correlations in gene-expression data whereas biologically-significant genes exhibit both positive and negative correlations. To address these problems, we propose a faster method for construction and analysis of gene-gene network and extraction of modules using a similarity measure which can identify both negatively and positively correlated co-expressed patterns. Our method utilizes General-purpose computing on graphics processing units (GPGPU) to provide fast, efficient and parallel extraction of biologically relevant network modules to support biomarker identification for breast cancer. The modules extracted are validated using p-value and q-value for both metastasis and non-metastasis stages of breast cancer. PNME has been found capable of identifying interesting biomarkers for this critical disease. We identified six genes with the interesting behaviours which have been found to cause breast cancer in homo-sapiens.Entities:
Keywords: Coexpression network; Generalized topological overlap measure; Graphical processing unit; Module extraction
Year: 2018 PMID: 30733759 PMCID: PMC6353772 DOI: 10.1016/j.jgeb.2018.08.003
Source DB: PubMed Journal: J Genet Eng Biotechnol ISSN: 1687-157X
p-Values and q-values for tests on Metastasis for GTOM1.
| p-Value with | q-Value with | |||||||
|---|---|---|---|---|---|---|---|---|
| 1.26E−5 | 1.04E−4 | 2.05E−4 | 2.3E−5 | 5.0E−2 | 8.3E−2 | 1.9E−2 | 2.2E−2 | |
| 2.74E−4 | 1.73E−4 | 1.75E−4 | 2.67E−4 | 1.1E−1 | 1.51E−1 | 1.5E−1 | 1.6E−1 | |
| 2.1E−4 | 2.9E−4 | 9.4E−4 | 2.14E−4 | 1.85E−1 | 1.4E−1 | 1.64E−1 | 1.18E−1 | |
| 6.4E−4 | 2.5E−4 | 3.13E−4 | 7.2E−4 | 1.5E−1 | 1.20E−1 | 8.67E−2 | 8.6E−2 | |
p-Values and q-values for tests on Non-metastasis for GTOM1.
| p-value with | q-value with | |||||||
|---|---|---|---|---|---|---|---|---|
| 8.4E−7 | 2.04E−5 | 4.3E−5 | 8.5E−4 | 8.5E−4 | 2.37E−2 | 7.07E−2 | 7.6E−2 | |
| 1.75E−5 | 8.6E−5 | 1.31E−4 | 8.63E−5 | 2.3E−2 | 7.7E−2 | 6.7E−2 | 7.8E−2 | |
| 9.4E−5 | 1.50E−5 | 1.7E−4 | 5.5E−4 | 1.0E−1 | 1.37E−2 | 5.6E−2 | 3.54E−2 | |
| 1.67E−3 | 1.04E−3 | 3.7E−4 | 2.81E−4 | 1.74E−1 | 1.53E−1 | 1.2E−1 | 7.93E−2 | |
p-Values and q-values for tests on Metastasis for GTOM2.
| p-value with | q-value with | |||||||
|---|---|---|---|---|---|---|---|---|
| 9.31E−8 | 2.48E−6 | 1.85E−5 | 2.85E−6 | 5.0E−5 | 4.1E−3 | 3.67E−2 | 4.52E−3 | |
| 2.6E−5 | 4.6E−5 | 1.52E−5 | 5.44E−6 | 4.4E−2 | 4.8E−2 | 2.41E−2 | 7.1E−3 | |
| 2.67E−6 | 2.72E−5 | 7.49E−5 | 3.33E−4 | 5.02E−3 | 2.4E−2 | 1.07E−1 | 1.38E−1 | |
| 1.7E−4 | 1.55E−3 | 1.04E−3 | 3.91E−4 | 1.10E−1 | 1.07E−1 | 8.9E−2 | 7.63E−2 | |
p-Values and q-values for tests on Non-Metastasis for GTOM2.
| p-value with | q-value with | |||||||
|---|---|---|---|---|---|---|---|---|
| 8.7E−14 | 1.8E−12 | 2.0E−8 | 3.9E−6 | 3.9E−10 | 3.2E−10 | 5.3E−5 | 8.75E−3 | |
| 9.3E−9 | 2.2E−6 | 1.2E−4 | 9.9E−5 | 2.5E−5 | 5.2E−3 | 4.2E−2 | 4.8E−2 | |
| 4.9E−5 | 3.7E−5 | 9.2E−6 | 1.6E−4 | 3.8E−2 | 5.5E−2 | 1.19E−2 | 6.39E−2 | |
| 2.2E−3 | 1.66E−6 | 7.7E−3 | 1.82E−2 | 1.82E−1 | 6.4E−4 | 9.8E−2 | 1.4E−1 | |
p-Values and q-values for tests on Metastasis for GTOM3.
| P-value with | Q-value with | |||||||
|---|---|---|---|---|---|---|---|---|
| 1.9E−7 | 1.1E−6 | 4.22E−6 | 5.9E−6 | 5.2E−4 | 2.46E−3 | 7.7E−3 | 8.58E−3 | |
| 6.8E−5 | 1.6E−5 | 4.4E−6 | 9.8E−7 | 5.1E−2 | 2.8E−2 | 6.21E−3 | 1.08E−3 | |
| 3.6E−5 | 37.4E−5 | 9.2E−5 | 1.54E−4 | 2.2E−2 | 1.06E−1 | 6.8E−2 | 9.8E−2 | |
| 1.71E−3 | 1.7E−4 | 8.1E−4 | 3.9E−4 | 1.1E−1 | 1.1E−1 | 8.98E−2 | 7.63E−2 | |
p-Values and q-values for tests on Non-Metastasis for GTOM3.
| P-value with | Q-value with | |||||||
|---|---|---|---|---|---|---|---|---|
| 8.5E−12 | 3.5E−8 | 2.2E−6 | 1.09E−5 | 2.6E−8 | 9.4E−5 | 2.84E−3 | 2.03E−2 | |
| 1.2E−6 | 8.58E−6 | 7.8E−5 | 4.10E−5 | 3.02E−3 | 1.42E−2 | 3.8E−2 | 3.5E−2 | |
| 9.8E−4 | 3.4E−3 | 3.4E−3 | 1.1E−4 | 1.1E−1 | 9.6E−2 | 6.7E−2 | 4.91E−2 | |
| 7.54E−4 | 65E−3 | 1.09E−2 | 2.16E−2 | 1.1E−1 | 1.05E−1 | 9.4E−2 | 1.44E−1 | |
Fig. 1Conceptual framework for parallel gene-gene network module extraction.
Fig. 2Variation of degrees of each casual gene in each stage.
Fig. 3Figure (a): highly connected genes in Non-Metastasis Stage, figure (b): highly connected genes in Metastasis Stage.
Fig. 5Computation time for different GTOMm (m from 1 to 4) in GPU and CPU.
Fig. 6Pathways in cancer of secondary genes in Non-metastasis. The above figure is generated using genemania [https://genemania.org/] [44].
Secondary genes following same pathways as primary genes in Non-metastasis stage.
| Non-Metastasis stage | ||||
|---|---|---|---|---|
| Primary Genes(P) | Degree(Dp) | Seconday Genes(S) | Degree(Ds) | KEGG Pathways |
| CDH1 | 55 | TRAF4 | 18 | Pathways in cancer |
| CDH1 | 55 | FH | 11 | Pathways in cancer |
| PAK1 | 30 | RASGRP1 | 52 | T cell receptor signaling pathway |
| PAK1 | 30 | LAMA4 | 39 | Focal adhesion |
| FGFR2 | 25 | PDGFRA | 50 | Pathways in cancer |
| NRP1 | 22 | EPHB3 | 48 | Axon guidance |
| CASP8 | 18 | BIRC3 | 39 | Pathways in cancer |
Secondary genes following same pathways as primary genes in metastasis stage.
| Metastasis stage | ||||
|---|---|---|---|---|
| Primary Genes(P) | Degree(Dp) | Secondary Genes(S) | Degree(Ds) | KEGG Pathways |
| CDH1 | 41 | FH | 7 | Pathways in cancer |
| PAK1 | 25 | RASGRP1 | 35 | T-cell Receptor Signalling Pathway |
| PAK1 | 25 | LAMA4 | 25 | Focal adhesion |
| EGFR | 19 | FAS | 18 | Pathways in cancer |
| NRP1 | 15 | EPHB3 | 40 | Axon guidance |
Fig. 7Pathways in cancer of secondary genes in metastasis.The above figure is generated using genemania [https://genemania.org/] [44].
Fig. 4Network between 10 primary and 6 secondary genes on (a) non-metastasis stage and (b) metastasis stage.
Degree of each secondary genes on network made from 10 primary and 6 secondary genes.
| Non-metastasis | Metastasis | ||
|---|---|---|---|
| Gene names | Degree | Gene names | Degee |
| TRAF4 | 6 | TRAF4 | – |
| LAMA4 | 4 | LAMA4 | 3 |
| FAS | – | FAS | 5 |
| PDGFRA | 1 | PDGFRA | – |
| BIRC3 | 5 | BIRC3 | – |
| EPHB3 | 7 | EPHB3 | 8 |